𝔖 Bobbio Scriptorium

✦ LIBER ✦

Administration of inotropic agents for safe intravenous epoprostenol therapy in patients with primary pulmonary hypertension

✍ Scribed by Miyaji Katsumasa; Nakamura Kazufumi; Nagase Satoshi; Saito Hironori; Kusano Kengo; Tetsuro Emori; Ohe Tohru

Book ID: 119212761
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 53 KB
Volume: 10
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2004.08.131

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Barst RJ, Rubin LJ, Long WA, For the Pri

Barst RJ, Rubin LJ, Long WA, For the Primary Pulmonary Hypertension Study Group^ ,Comparaison entre l'époprosténol (prostacycline) en continu par voie veineuse et le traitement conventionnel dans l'hypertension artérielle pulmonaire primitive A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 (1996) 296 301.

✍ Patrick Jego 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 271 KB

Efficacy and Safety of IgPro20, a 20% Im

Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy

✍ Stephen Jolles; Victor Cristea; Volker Wahn; Marianne Debré; Hilary Longhurst; O 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A comparison of continuous intravenous e

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, B.M. Groves, V.F. Tapson, R.C. Bourge, B.H. Brundage, S.K. Koerner, D. Langleben, C.A. Keller, S. Murali, B.F. Uretsky, L.M. Clayton, M.M. Jobsis, S.D. Blackburn, Jr. et al. Department of Pediatrics, Columbia University, College of Physicians and Surgeons, New York, NY. N Engl J Med 1996;334:296–301

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 115 KB